Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Vertex Experimental Drug Cuts Off Pain at the Source, Company Says

Vertex Pharmaceuticals said its medicine could address moderate to severe acute pain, and might be able to avoid the risk of addiction.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Opioids and Opiates, Pain-Relieving Drugs, Vertex Pharmaceuticals Inc
←G.M. Profits Hurt by Unsold Electric Vehicles and Strike
After Claiming Wage Theft, Some Uber & Lyft Drivers Are Eligible To Receive A Payout From Landmark $328M Settlement→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube